Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling.

Terza JV, Basu A, Rathouz PJ.

J Health Econ. 2008 May;27(3):531-43. doi: 10.1016/j.jhealeco.2007.09.009. Epub 2007 Dec 4.

PMID:
18192044
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Multilevel models and health economics.

Rice N, Jones A.

Health Econ. 1997 Nov-Dec;6(6):561-75. Review.

PMID:
9466139
[PubMed - indexed for MEDLINE]
3.

Statistical assessment of the learning curves of health technologies.

Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF, Russell IT.

Health Technol Assess. 2001;5(12):1-79. Review.

PMID:
11319991
[PubMed - indexed for MEDLINE]
Free Article
4.

Addressing the identification problem in age-period-cohort analysis: a tutorial on the use of partial least squares and principal components analysis.

Tu YK, Krämer N, Lee WC.

Epidemiology. 2012 Jul;23(4):583-93. doi: 10.1097/EDE.0b013e31824d57a9. Review.

PMID:
22407139
[PubMed - indexed for MEDLINE]
5.

Estimating dose-response effects in psychological treatment trials: the role of instrumental variables.

Maracy M, Dunn G.

Stat Methods Med Res. 2011 Jun;20(3):191-215. doi: 10.1177/0962280208097243. Epub 2008 Nov 26. Review.

PMID:
19036909
[PubMed - indexed for MEDLINE]
6.

Econometric analyses of national health expenditures: can positive economics help to answer normative questions?

McGuire A, Parkin D, Hughes D, Gerard K.

Health Econ. 1993 Jul;2(2):113-26. Review.

PMID:
8261033
[PubMed - indexed for MEDLINE]
7.

The value of a statistical life: theoretical and empirical evidence.

Johansson PO.

Appl Health Econ Health Policy. 2002;1(1):33-41. Review.

PMID:
14618746
[PubMed - indexed for MEDLINE]
8.

Guidelines for selecting among different types of bootstraps.

Baser O, Crown WH, Pollicino C.

Curr Med Res Opin. 2006 Apr;22(4):799-808. Review.

PMID:
16684441
[PubMed - indexed for MEDLINE]
9.

Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them.

Koch GG, Tangen CM, Jung JW, Amara IA.

Stat Med. 1998 Aug 15-30;17(15-16):1863-92. Review.

PMID:
9749453
[PubMed - indexed for MEDLINE]
10.

Methods to assess intended effects of drug treatment in observational studies are reviewed.

Klungel OH, Martens EP, Psaty BM, Grobbee DE, Sullivan SD, Stricker BH, Leufkens HG, de Boer A.

J Clin Epidemiol. 2004 Dec;57(12):1223-31. Review.

PMID:
15617947
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk